| 000 | 01744 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250517095434.0 | ||
| 264 | 0 | _c20180515 | |
| 008 | 201805s 0 0 eng d | ||
| 022 | _a2045-2322 | ||
| 024 | 7 |
_a10.1038/srep26490 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGresnigt, Mark S | |
| 245 | 0 | 0 |
_aReducing hypoxia and inflammation during invasive pulmonary aspergillosis by targeting the Interleukin-1 receptor. _h[electronic resource] |
| 260 |
_bScientific reports _c05 2016 |
||
| 300 |
_a26490 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdrenal Cortex Hormones _xadverse effects |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCarbonic Anhydrase IX _xmetabolism |
| 650 | 0 | 4 |
_aCell Hypoxia _xdrug effects |
| 650 | 0 | 4 |
_aCytokines _xmetabolism |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aImmunocompromised Host |
| 650 | 0 | 4 |
_aInterleukin 1 Receptor Antagonist Protein _xadministration & dosage |
| 650 | 0 | 4 |
_aInvasive Pulmonary Aspergillosis _xdrug therapy |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aReceptors, Interleukin-1 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aReceptors, Interleukin-8B _xdeficiency |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aRekiki, Abdessalem | |
| 700 | 1 | _aRasid, Orhan | |
| 700 | 1 | _aSavers, Amélie | |
| 700 | 1 | _aJouvion, Grégory | |
| 700 | 1 | _aDannaoui, Eric | |
| 700 | 1 | _aParlato, Marianna | |
| 700 | 1 | _aFitting, Catherine | |
| 700 | 1 | _aBrock, Matthias | |
| 700 | 1 | _aCavaillon, Jean-Marc | |
| 700 | 1 | _avan de Veerdonk, Frank L | |
| 700 | 1 | _aIbrahim-Granet, Oumaïma | |
| 773 | 0 |
_tScientific reports _gvol. 6 _gp. 26490 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/srep26490 _zAvailable from publisher's website |
| 999 |
_c26051064 _d26051064 |
||